Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.

Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC.

J Neurol Neurosurg Psychiatry. 2011 May;82(5):476-86. doi: 10.1136/jnnp.2010.212225. Epub 2010 Oct 22. Review.

PMID:
20971753
2.

Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN).

Gabryelewicz T, Masellis M, Berdynski M, Bilbao JM, Rogaeva E, St George-Hyslop P, Barczak A, Czyzewski K, Barcikowska M, Wszolek Z, Black SE, Zekanowski C.

J Alzheimers Dis. 2010;22(4):1123-33. doi: 10.3233/JAD-2010-101413.

3.

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.

Mackenzie IR, Rademakers R, Neumann M.

Lancet Neurol. 2010 Oct;9(10):995-1007. doi: 10.1016/S1474-4422(10)70195-2. Review.

PMID:
20864052
4.

Frontotemporal dementia and primary progressive aphasia: an update.

Kirshner HS.

Curr Neurol Neurosci Rep. 2010 Nov;10(6):504-11. doi: 10.1007/s11910-010-0145-z.

PMID:
20717853
5.

Tau pathology and future therapeutics.

Gozes I.

Curr Alzheimer Res. 2010 Dec;7(8):685-96. Review.

PMID:
20678069
6.

Amyotrophic lateral sclerosis: current practice and future treatments.

Bedlack RS.

Curr Opin Neurol. 2010 Oct;23(5):524-9. doi: 10.1097/WCO.0b013e32833c7ac2. Review.

PMID:
20613515
7.

Clinical staging and disease progression in frontotemporal dementia.

Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR.

Neurology. 2010 May 18;74(20):1591-7. doi: 10.1212/WNL.0b013e3181e04070.

PMID:
20479357
8.

Frontotemporal dementia, Pick's disease.

Kertesz A.

Ideggyogy Sz. 2010 Jan 30;63(1-2):4-12. Review.

PMID:
20420119
9.

Riluzole, neuroprotection and amyotrophic lateral sclerosis.

Cheah BC, Vucic S, Krishnan AV, Kiernan MC.

Curr Med Chem. 2010;17(18):1942-199. Review.

PMID:
20377511
10.
11.

Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.

Gordon E, Rohrer JD, Kim LG, Omar R, Rossor MN, Fox NC, Warren JD.

Neurology. 2010 Feb 23;74(8):666-73. doi: 10.1212/WNL.0b013e3181d1a879.

12.

Frontal variant of Alzheimer's disease: clinico-CSF-pathological correlation.

Habek M, Hajnsek S, Zarković K, Chudy D, Mubrin Z.

Can J Neurol Sci. 2010 Jan;37(1):118-20. No abstract available.

PMID:
20169785
13.

Frontotemporal dementia and pharmacologic interventions.

Kaye ED, Petrovic-Poljak A, Verhoeff NP, Freedman M.

J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):19-29. doi: 10.1176/appi.neuropsych.22.1.19. Review.

PMID:
20160206
14.

The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM.

Arch Neurol. 2010 Feb;67(2):161-70. doi: 10.1001/archneurol.2009.328.

15.

Off-label medication use in frontotemporal dementia.

Bei Hu, Ross L, Neuhaus J, Knopman D, Kramer J, Boeve B, Caselli RJ, Graff-Radford N, Mendez MF, Miller BL, Boxer AL.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):128-33. doi: 10.1177/1533317509356692. Epub 2010 Feb 1.

16.

Update on frontotemporal dementia.

Arvanitakis Z.

Neurologist. 2010 Jan;16(1):16-22. doi: 10.1097/NRL.0b013e3181b1d5c6. Review.

17.

Impact of FDA black box advisory on antipsychotic medication use.

Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC.

Arch Intern Med. 2010 Jan 11;170(1):96-103. doi: 10.1001/archinternmed.2009.456.

18.

FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.

Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, Blumbergs PC, Vucic S, Kiernan MC, Nicholson GA.

J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):639-45. doi: 10.1136/jnnp.2009.194399. Epub 2009 Dec 3.

PMID:
19965854
19.

Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertraline.

Prodan CI, Monnot M, Ross ED.

J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1416-7. doi: 10.1136/jnnp.2009.173260. No abstract available.

PMID:
19917830
20.

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2009 Oct 13;73(15):1218-26. doi: 10.1212/WNL.0b013e3181bc0141. Review. Erratum in: Neurology. 2010 Mar 2;74(9):781. Neurology. 2009 Dec 15;73(24):2134.

Supplemental Content

Support Center